Weight Loss Injection Risks: What the UK Evidence Says (October 2026)

01 · The short answer

What are the risks of weight loss injections?

The risks fall into three groups: everyday side effects that most people meet at some point, uncommon serious conditions that need urgent care, and risks that come from who you are or how you buy the medicine. Understanding which group a worry belongs to is the quickest way to judge it sensibly.

On the everyday side, the commonest early effects are mild nausea, altered appetite and tiredness in the days after each injection, and they usually settle.¹ The 2.5mg starting weeks are about adjustment, not weight loss, so the body gets time to get used to the medicine.¹

On the serious side, the conditions to know are pancreatitis, gallbladder problems and severe allergic reaction. These are uncommon, but the warning signs are specific and worth knowing. For a wider look at the class, our guide to the risks of weight loss drugs and our blog on whether weight loss injections are safe go further.

02 · At a glance

Risk summary table

03 · Your decision

Are these risks relevant to you?

They are most relevant if you already have a condition on the caution list, take other medicines, or are planning pregnancy. For most healthy adults who meet the licensed criteria, the realistic experience is early, mild digestive effects while the dose steps up, rather than serious harm.

The decision in front of you is usually not "is this risk-free?" because no medicine is. It is whether the likely benefit for your health outweighs the known risks, with a prescriber looking at your actual history.

Related guides: Hse weight loss injections and Retina weight loss injection.

04 · Common side effects

Common side effects of weight loss injections

The commonest side effects are mild nausea, altered appetite and tiredness in the first days after each injection, and they usually settle.¹ That pattern makes sense given how the medicine works: it helps regulate appetite and slows how quickly the stomach empties.¹

Experiences differ widely. Some people notice an appetite change and early loss in the first week, while others feel little until a higher dose. Both are normal.¹ Many people choose a weekend morning to inject so that early effects fall on days off, though Mounjaro works the same morning or evening, with or without food.¹

The complete list of side effects, with how often each occurs, is in the patient information leaflet.¹³ Read it before your first injection, and keep it to hand when the dose increases, since side effects can return at each step up.

05 · Serious side effects

Serious side effects and when to seek help

Serious side effects are uncommon but need urgent attention. Seek immediate medical help for: severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin/eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing.¹³

Do not wait to see whether these pass; get medical help straight away, and do not take another injection until you have been assessed. Tell the clinician you are using a weight loss injection so they can factor it in.

If you take insulin or a sulfonylurea alongside Mounjaro, watch for low blood sugar (shakiness, sweating, confusion). Your prescriber may need to adjust those medicines.¹³ This is a reason to be open about every medicine on your list, not a reason to avoid treatment.

06 · Who should avoid them

Who should not use a weight loss injection

Mounjaro is not suitable for everyone. You should not take it if you are allergic to tirzepatide or any of its ingredients, and it should not be used during pregnancy or while trying to conceive.¹ Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly.

Your prescriber will take extra care, or may recommend against treatment, if you have a history of pancreatitis, severe gut or digestive disease, diabetic retinopathy, or gallbladder problems.¹ Always share your full medical history and medicine list during consultation.

Licensing matters too. Mounjaro is licensed for weight management in adults with a BMI of 30 or above, or a BMI between 27 and 30 with at least one weight-related condition such as high blood pressure, high cholesterol, obstructive sleep apnoea, cardiovascular disease, prediabetes or type 2 diabetes.¹ It must be used alongside a reduced-calorie diet and increased physical activity. Using it outside those criteria means the benefit-risk balance has not been assessed in the same way.

07 · Thyroid and organ risks

Thyroid, kidney and liver questions

The thyroid warning comes from animal work, not human evidence. In rodent studies tirzepatide caused thyroid C-cell tumours; it is not known whether this applies to humans, and no increase has been shown in human trials.¹ As a precaution, tell your prescriber if you or a close relative have had medullary thyroid cancer or the inherited condition MEN 2. They will weigh this in your assessment. Routine thyroid monitoring is not required for most people.¹

For kidneys and liver, Mounjaro is not known to damage either directly, and no dose adjustment is needed for mild to moderate impairment.¹ The practical risk is indirect: severe vomiting or diarrhoea can cause dehydration, which can strain the kidneys. Keep fluids up and get medical help straight away if you cannot keep fluids down. People with severe impairment need individual prescriber assessment.¹

08 · Buying and dosing risks

Risks that come from how you buy or use them

Some of the biggest avoidable risks have nothing to do with the molecule. They come from unregulated supply and from altering the dose. Mounjaro is a prescription-only medicine, so anyone offering to supply without a consultation or prescription is a red flag. The MHRA publishes counterfeit medicine alerts and runs the Yellow Card scheme for reporting problems.⁷ You can confirm a pharmacy on the GPhC register (ours is GPhC 9012878).¹²

Altering doses outside the licence means unknown dosing accuracy and no safety data.¹

Storage is a smaller but real safety point. Keep pens in a fridge at 2–8°C and never freeze them. Once in use, a pen can be kept out of the fridge not above 30°C for up to 30 days, after which it should be discarded.¹

09 · NHS weight loss jabs

NHS weight loss jabs: are the risks different?

The medicine carries the same risks whether it comes through the NHS or a private pharmacy. What differs is the route to supply and the follow-up. Mounjaro is available on the NHS, but access is being phased in over several years.⁴⁶

Because the rollout began with the highest-need groups first, many people who meet the licensed criteria look at regulated private treatment instead of waiting. The safety standard to look for is the same either way: a clinician reviewing your history, a licensed product, and follow-up when the dose changes.⁴

10 · Stopping and results

Stopping treatment and judging whether it is working

Coming off the medicine is not an emergency, and nothing needs doing while it clears. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up.¹ Talk to your prescriber before stopping so you have a plan for appetite and eating once the effect fades. Mounjaro manages weight; it does not cure the biology behind it. In SURMOUNT-4, people who stopped tirzepatide after 36 weeks regained on average 14% of body weight over the following year, while those who continued treatment lost a further 5.5% on average. Stopping should always be planned with your prescriber, with diet and activity habits ready to carry the load.

Risk also includes expecting the wrong thing. Weight loss on Mounjaro is gradual by design, and trials measured results at 72 weeks, so think in months, not days, and judge progress by trend rather than individual weigh-ins.² Treatment response is reviewed by your prescriber: if you have lost less than 5% of your starting weight after 6 months on the highest dose you can tolerate, your prescriber will discuss whether continuing or stopping is right for you.⁴

If you notice a new symptom that you are unsure about, discuss it with your prescriber and report it through the Yellow Card scheme.¹⁹

11 · How we reduce risk

How a regulated pharmacy reduces the risks

A regulated route puts a clinician between you and the pen. At EverydayMeds, the consultation is free, and your answers are reviewed by a GPhC-registered prescriber, not a scoring script. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

Our pens come through official LillyDirect supply, direct from Eli Lilly's UK distribution, so they are genuine KwikPens. Delivery is free, next-day, tracked and temperature-controlled. Needles, a sharps bin and injection guidance come with every order, and ongoing monthly reviews cover dose changes and side-effect support. Repeat orders re-check suitability, with no auto-shipping.

For a walkthrough of the sign-up process, see our page on registering online for weight loss injections.